Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at ...
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
An international working group of canine cognition experts has released a set of guidelines for veterinarians to use in ...
At home blood tests could soon be used to diagnose dementia, revolutionising dementia care and treatment access.
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
A watch that can potentially identify early signs of dementia, a toothbrush that can smell diabetes and a robot that can fold ...
Last month, Illinois Gov. JB Pritzker signed into law a bill lawmakers passed called “Deb’s Law” that enables terminally ill patients to request a prescription from their doctor to end their ...
Morning Overview on MSN
New brain clue points to a different way to treat dementia
Dementia research is shifting from chasing plaques to decoding how the brain maintains its own health, from blood flow and ...
Increasing the levels of a particular phospholipid in the membranes of brain cells may offer a promising new way to improve blood circulation in the brain and support healthier brain activity. A poten ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results